Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
William W. Wheaton,Samuel E. Weinberg,Robert B. Hamanaka,Saul Soberanes,Lucas B. Sullivan,Elena Anso,Andrea Glasauer,Eric Dufour,Gökhan M. Mutlu,GR Scott Budigner,Navdeep S. Chandel +10 more
Reads0
Chats0
TLDR
In human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrogenase) activity and cellular respiration, indicating that cancer cells rely exclusively on glycolysis for survival in the presence of meetformin.Abstract:
Metformin is widely used to reduce the high blood sugar levels caused by diabetes. Recently, several studies have suggested that patients taking metformin who also develop cancer have tumors that grow more slowly than average. As clinical trials have already started to investigate if metformin is an effective anti-cancer treatment, it is important to understand how it might restrict tumor growth. Researchers have proposed two ways that metformin could affect tumors. First, insulin is known to prompt cancer cells to divide, so the slower rate of tumor growth could just be a side-effect of the metformin reducing the amount of insulin in the blood. Alternatively, metformin could target cancer cells more directly by cutting the energy supply produced by their mitochondria. Metformin has been shown to disrupt complex I of the electron transport chain that is used by cells to generate energy. However, it is not known if disrupting complex I would actually stop cells dividing because they can generate energy in other ways. Wheaton, Weinberg et al. have now demonstrated that metformin does target complex I in cancer cells, and that its effects depend on the amount of glucose available for cells to convert, without involving mitochondria, into energy. When there is plenty of glucose, metformin slows down the rate at which cancer cells divide, which slows down tumor growth. When the cells are deprived of glucose, metformin kills the cells instead. Metformin also inhibits the pathways that regulate hypoxia inducible factors (HIFs), which are part of a system that helps cells to survive low-oxygen conditions, a prominent feature of many tumors. This means that metformin may combat cancer more effectively if used alongside other treatments that reduce the availability of both oxygen and glucose inside cells. Metformin could also potentially treat conditions that are linked to overactive HIFs, such as pulmonary hypertension.read more
Citations
More filters
Journal ArticleDOI
Fundamentals of cancer metabolism
TL;DR: A conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis will progressively support the development of new strategies to treat human cancer.
Journal ArticleDOI
Understanding the Intersections between Metabolism and Cancer Biology
TL;DR: In this paper, the authors define pathways that are limiting for cancer progression and understand the context specificity of metabolic preferences and liabilities in malignant cells, which can guide the more effective targeting of metabolism to help patients.
Journal ArticleDOI
ROS signalling in the biology of cancer.
TL;DR: The generation and sources of ROS within tumour cells, the regulation of ROS by antioxidant defence systems, as well as the effect of elevated ROS production on their signalling targets in cancer are discussed.
Journal ArticleDOI
Targeting mitochondria metabolism for cancer therapy
TL;DR: Accumulating evidence now suggests that mitochondrial bioenergetics, biosynthesis and signaling are required for tumorigenesis, and emerging studies have begun to demonstrate that mitochondrial metabolism is potentially a fruitful arena for cancer therapy.
Journal ArticleDOI
Metformin: From Mechanisms of Action to Therapies
Marc Foretz,Bruno Guigas,Luc Bertrand,Michael Pollak,Benoit Viollet,Benoit Viollet,Benoit Viollet +6 more
TL;DR: Convincing data place energy metabolism at the center of metformin's mechanism of action in diabetes and may also be of importance in cardiovascular diseases and cancer.
References
More filters
Journal ArticleDOI
Dose translation from animal to human studies revisited
TL;DR: BSA correlates well across several mammalian species with several parameters of biology, including oxygen utilization, caloric expenditure, basal metabolism, blood volume, circulating plasma proteins, and renal function, and is advocated as a factor when converting a dose for translation from animals to humans.
Journal ArticleDOI
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan,John B. Buse,Mayer B. Davidson,Ele Ferrannini,Rury R. Holman,Robert S. Sherwin,Bernard Zinman +6 more
TL;DR: This revision of the consensus algorithm for the medical management of type 2 diabetes focuses on the new classes of medications that now have more clinical data and experience and addresses safety issues surrounding the thiazolidinediones.
Journal ArticleDOI
Hypoxia-Inducible Factors in Physiology and Medicine
TL;DR: Oxygen homeostasis represents an organizing principle for understanding metazoan evolution, development, physiology, and pathobiology and rapid progress is being made in elucidating homeostatic roles of HIFs in many physiological systems, determining pathological consequences of H IF dysregulation in chronic diseases, and investigating potential targeting of Hifs for therapeutic purposes.
Journal ArticleDOI
Metformin and reduced risk of cancer in diabetic patients
TL;DR: It is hypothesised that metformin use in patients with type 2 diabetes may reduce their risk of cancer and tested this hypothesis using record linkage databases developed in Tayside, Scotland: a diabetes clinical information system (DARTS) and a database of dispensed prescriptions (MEMO).
Journal ArticleDOI
Physiological roles of mitochondrial reactive oxygen species.
Laura A. Sena,Navdeep S. Chandel +1 more
TL;DR: More and more evidence suggests that mROS are critical for healthy cell function, and this evidence is discussed following some background on the generation and regulation ofmROS.